Abstract |
All-trans-retinoic acid (ATRA), a vitamin A derivative, was reported to suppress the interleukin-6 (IL-6) production and to downregulate the IL-6 receptor (IL-6R) and/or its signal transducer glycoprotein 130. We investigated the in vivo antinephritic effect of ATRA on IL-6 transgenic mice which had developed mesangial proliferative glomerulonephritis (PGN) as well as its in vitro inhibitory effect on the proliferation of rat mesangial cells. In vivo experiments on IL-6 transgenic mice showed that ATRA administration suppressed proteinuria and hematuria and reduced the IL-6 concentrations; furthermore, histological examination demonstrated that it improved PGN. In vitro experiments using rat mesangial cells demonstrated that ATRA inhibited cell growth in a dose-dependent manner within a range from 10(-4) to 10(-6) M. This inhibition by ATRA was partially counteracted by the addition of IL-6. RT-PCR assay results showed that ATRA also reduced IL-6R, but not the glycoprotein 130 expression in mesangial cells. These findings indicate that, by blocking of the IL-6 function, ATRA may be therapeutically effective in PGN.
|
Authors | Yoshihito Shima, Masayuki Iwano, Kazuyuki Yoshizaki, Toshio Tanaka, Ichiro Kawase, Norihiro Nishimoto |
Journal | Nephron. Experimental nephrology
(Nephron Exp Nephrol)
Vol. 100
Issue 1
Pg. e54-62
( 2005)
ISSN: 1660-2129 [Electronic] Switzerland |
PMID | 15795517
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Interleukin-6
- Receptors, Interleukin-6
- Cytokine Receptor gp130
- Tretinoin
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology)
- Cell Culture Techniques
- Cell Proliferation
- Cytokine Receptor gp130
(biosynthesis)
- Dose-Response Relationship, Drug
- Down-Regulation
- Glomerulonephritis
- Hematuria
- Interleukin-6
(biosynthesis, blood, genetics, physiology)
- Mice
- Mice, Transgenic
- Proteinuria
- Rats
- Receptors, Interleukin-6
(biosynthesis, physiology)
- Reverse Transcriptase Polymerase Chain Reaction
- Tretinoin
(pharmacology)
|